mRNA for all: WHO establishes biomanufacturing training hub in Korea
The WHO and South Korea’s government on Wednesday unveiled a new global biomanufacturing training hub in Seoul that will help low- and middle-income countries train more people to produce vaccines, insulin, monoclonal antibodies and cancer treatments worldwide.
Korea’s government offered a large facility outside Seoul that is already carrying out biomanufacturing training for companies based in the country and will now expand its operations to accommodate trainees from other countries.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,600+ biopharma pros reading Endpoints daily — and it's free.